These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8629600)

  • 1. Inhaled nitric oxide to test the vasodilator capacity of the pulmonary vascular bed in children with long-standing pulmonary hypertension and congenital heart disease.
    Berner M; Beghetti M; Spahr-Schopfer I; Oberhansli I; Friedli B
    Am J Cardiol; 1996 Mar; 77(7):532-5. PubMed ID: 8629600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhaled nitric oxide versus aerosolized iloprost in secondary pulmonary hypertension in children with congenital heart disease: vasodilator capacity and cellular mechanisms.
    Rimensberger PC; Spahr-Schopfer I; Berner M; Jaeggi E; Kalangos A; Friedli B; Beghetti M
    Circulation; 2001 Jan; 103(4):544-8. PubMed ID: 11157720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aerosolized iloprost for pulmonary vasoreactivity testing in children with long-standing pulmonary hypertension related to congenital heart disease.
    Limsuwan A; Khosithseth A; Wanichkul S; Khowsathit P
    Catheter Cardiovasc Interv; 2009 Jan; 73(1):98-104. PubMed ID: 19089967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of inhaled nitric oxide on raised pulmonary vascular resistance in children with congenital heart disease.
    Winberg P; Lundell BP; Gustafsson LE
    Br Heart J; 1994 Mar; 71(3):282-6. PubMed ID: 8142199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Very-low-dose inhaled nitric oxide: a selective pulmonary vasodilator after operations for congenital heart disease.
    Miller OI; Celermajer DS; Deanfield JE; Macrae DJ
    J Thorac Cardiovasc Surg; 1994 Sep; 108(3):487-94. PubMed ID: 8078341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhaled nitric oxide in children with pulmonary hypertension and congenital mitral stenosis.
    Atz AM; Adatia I; Jonas RA; Wessel DL
    Am J Cardiol; 1996 Feb; 77(4):316-9. PubMed ID: 8607419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of low dosage inhaled nitric oxide on pulmonary hypertension in congenital heart disease.
    Kazue T
    Kurume Med J; 1995; 42(4):281-90. PubMed ID: 8667600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhaled nitric oxide in congenital heart disease.
    Roberts JD; Lang P; Bigatello LM; Vlahakes GJ; Zapol WM
    Circulation; 1993 Feb; 87(2):447-53. PubMed ID: 8425292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined effects of nitric oxide and oxygen during acute pulmonary vasodilator testing.
    Atz AM; Adatia I; Lock JE; Wessel DL
    J Am Coll Cardiol; 1999 Mar; 33(3):813-9. PubMed ID: 10080486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhaled nitric oxide for perioperative management of an adult patient with atrial septal defect and severe pulmonary hypertension.
    Kim JH; Ham BM; Kim YL; Ahn H; Noh CI
    J Cardiothorac Vasc Anesth; 2002 Dec; 16(6):746-8. PubMed ID: 12486659
    [No Abstract]   [Full Text] [Related]  

  • 11. Acute effect of oral prostacyclin and inhaled nitric oxide on pulmonary hypertension in children.
    Ichida F; Uese K; Hashimoto I; Hamamichi Y; Tsubata S; Fukahara K; Murakami A; Miyawaki T
    J Cardiol; 1997 Apr; 29(4):217-24. PubMed ID: 9127838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of inhaled nitric oxide on postoperative pulmonary circulation in patients with congenital heart disease.
    Matsui J; Yahagi N; Kumon K; Hayashi H; Watanabe Y; Haruna M; Tanigami H; Yagihara T; Takamoto S; Kamiya T
    Artif Organs; 1997 Jan; 21(1):17-20. PubMed ID: 9012900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary vasodilation by nitric oxide gas and prodrug aerosols in acute pulmonary hypertension.
    Adrie C; Ichinose F; Holzmann A; Keefer L; Hurford WE; Zapol WM
    J Appl Physiol (1985); 1998 Feb; 84(2):435-41. PubMed ID: 9475849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PGI2 aerosol versus nitric oxide for selective pulmonary vasodilation in hypoxic pulmonary vasoconstriction.
    Welte M; Zwissler B; Habazettl H; Messmer K
    Eur Surg Res; 1993; 25(5):329-40. PubMed ID: 8404993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atrial natriuretic peptide and nitric oxide in children with pulmonary hypertension after surgical repair of congenital heart disease.
    Ivy DD; Kinsella JP; Wolfe RR; Abman SH
    Am J Cardiol; 1996 Jan; 77(1):102-5. PubMed ID: 8540445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute Pulmonary Vasodilator Testing and Long-Term Clinical Course in Segmental Pulmonary Vascular Disease.
    Domingo L; Magdo HS; Day RW
    Pediatr Cardiol; 2018 Mar; 39(3):501-508. PubMed ID: 29196781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous sildenafil is a potent pulmonary vasodilator in children with congenital heart disease.
    Schulze-Neick I; Hartenstein P; Li J; Stiller B; Nagdyman N; Hübler M; Butrous G; Petros A; Lange P; Redington AN
    Circulation; 2003 Sep; 108 Suppl 1():II167-73. PubMed ID: 12970227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized controlled study of inhaled nitric oxide after operation for congenital heart disease.
    Day RW; Hawkins JA; McGough EC; Crezeé KL; Orsmond GS
    Ann Thorac Surg; 2000 Jun; 69(6):1907-12; discussion 1913. PubMed ID: 10892945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhaled nitric oxide in the neonate with cardiac disease.
    Atz AM; Wessel DL
    Semin Perinatol; 1997 Oct; 21(5):441-55. PubMed ID: 9352616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of dipyridamole and inhaled nitric oxide in pediatric patients with pulmonary hypertension.
    Ziegler JW; Ivy DD; Wiggins JW; Kinsella JP; Clarke WR; Abman SH
    Am J Respir Crit Care Med; 1998 Nov; 158(5 Pt 1):1388-95. PubMed ID: 9817684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.